Microba Life Sciences Ltd (ASX:MAP) CEO Dr Luke Reid speaks to Proactive's Thomas Warner about the company's work in developing gut microbiome testing services and associated therapeutics.
Reid says that microbiome testing will become "routine" during the coming years and that Microba is well-placed to take advantage of a potentially huge emerging market.